%0 Journal Article
%B American Journal of Kidney Diseases
%D 2014
%F R&M
%G Eng
%M 25115616
%T A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance with Oxpentifylline (HERO) trial
%V pii: S0272-6386(14)00987-1.
%7 2014/08/15
%@ 1523-6838 (Electronic)<br/>0272-6386 (Linking)